Development of potent dual PDK1/AurA kinase inhibitors for Ewing sarcoma therapy

被引：0
|
作者：
Riveiro, Maria Eugenia [1 ]
Huguet, Samuel [2 ]
Vazquez, Ramiro [1 ]
Frapolli, Roberta [3 ]
Puricelli, Guido [4 ]
Sestito, Simona [5 ]
Madar, Olivier [2 ]
Rezai, Keyvan [2 ]
Garau, Gianpiero [6 ]
Rapposelli, Simona [7 ]
机构：
[1] Early Drug Dev Grp, Boulogne, France
[2] Curie Inst, St Cloud, France
[3] Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy
[4] Int Soc Drug Discovery, Milan, Italy
[5] Univ Sassari, Sassari, Italy
[6] Ist Italiano Tecnol, Pisa, Italy
[7] Univ Pisa, Pisa, Italy
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2569
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Intracellular signalling: PDK1 - a kinase at the hub of things
    Belham, C
    Wu, SL
    Avruch, J
    CURRENT BIOLOGY, 1999, 9 (03) : R93 - R96
  • [22] Study of the PDK1/AKT signaling pathway using selective PDK1 inhibitors, HCS, and enhanced biochemical assays
    Hofler, Alexandra
    Nichols, Tim
    Grant, Stephan
    Lingardo, Laura
    Esposito, Edward A.
    Gridley, Scott
    Murphy, Sean T.
    Kath, John C.
    Cronin, Ciaran N.
    Kraus, Michelle
    Alton, Gordon
    Xie, Zhi
    Sutton, Scott
    Gehring, Mike
    Ermoliefff, Jacques
    ANALYTICAL BIOCHEMISTRY, 2011, 414 (02) : 179 - 186
  • [23] Stage-specific requirement of kinase PDK1 for NK cells development and activation
    Junming He
    Yuande Wang
    Tian Liu
    Guangao Liu
    Shasha Chen
    Qiaozhen Li
    Yuhe Quan
    Haoyan Yang
    Jin Feng
    Song Wang
    Meixiang Yang
    Zhongjun Dong
    Cell Death & Differentiation, 2019, 26 : 1918 - 1928
  • [24] Stage-specific requirement of kinase PDK1 for NK cells development and activation
    He, Junming
    Wang, Yuande
    Liu, Tian
    Liu, Guangao
    Chen, Shasha
    Li, Qiaozhen
    Quan, Yuhe
    Yang, Haoyan
    Feng, Jin
    Wang, Song
    Yang, Meixiang
    Dong, Zhongjun
    CELL DEATH AND DIFFERENTIATION, 2019, 26 (10): : 1918 - 1928
  • [25] PDK1, the master regulator of AGC kinase signal transduction
    Mora, A
    Komander, D
    van Aalten, DMF
    Alessi, DR
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (02) : 161 - 170
  • [26] GSK2334470: A potent and highly selective inhibitor of PDK1
    Axten, Jeffrey M.
    Medina, Jesus R.
    Shu, Arthur
    Li, William H.
    Feng, Yanhong
    DeYoung, M. Phillip
    Gardiner, Christine M.
    Chadderton, Antony R.
    Dumble, Melissa
    Liu, Qi
    Rabindran, Sridhar
    CANCER RESEARCH, 2010, 70
  • [27] Discovery of novel 7-azaindoles as PDK1 inhibitors
    Wucherer-Plietker, Margarita
    Merkul, Eugen
    Mueller, Thomas J. J.
    Esdar, Christina
    Knoechel, Thorsten
    Heinrich, Timo
    Buchstaller, Hans-Peter
    Greiner, Hartmut
    Dorsch, Dieter
    Finsinger, Dirk
    Calderini, Michel
    Bruge, David
    Graedler, Ulrich
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (13) : 3073 - 3080
  • [28] 3-Cyclohexylindoles: A new class of inhibitors of 3-phosphoinositide-dependent kinase 1 (PDK1)
    Kutterer, Kristina M. K.
    Tang, Zhilian
    Aplasca, Alexis
    Malana, Anthony
    Guo, Bing
    Han, Xin
    Arndt, Kim
    Gopalsamy, Ariamala
    Ellingboe, John W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 809 - 809
  • [29] A patent update on PDK1 inhibitors (2015-present)
    Sestito, Simona
    Rapposelli, Simona
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (04) : 271 - 282
  • [30] Design and characterization of α-lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors
    Lin, Hong-Yan
    Han, Hong-Wei
    Sun, Wen-Xue
    Yang, Yu-Shun
    Tang, Cheng-Yi
    Lu, Gui-Hua
    Qi, Jin-Liang
    Wang, Xiao-Ming
    Yang, Yong-Hua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 144 : 137 - 150
12345